Application of MEB2 gene in negative regulation of sclerotiniose resistance of plants
Through genome-wide association analysis and transgenic technology, the key role of MEB2 gene in regulating rapeseed's resistance to sclerosis was identified and verified, solving the problem that traditional methods are difficult to quickly obtain disease-resistant varieties, and achieving precise regulation of plant disease resistance and molecular marker-assisted selection.
Patent Information
- Application Number
- CN202510712649.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-30
- Publication Date
- 2025-07-01
- Estimated Expiration
- 2045-05-30
AI Technical Summary
Traditional methods are difficult to quickly obtain wheat varieties that are ideally resistant to sclerosis, and existing studies have shown that plants' resistance to sclerosis is controlled by multiple genes, which increases the difficulty of localization and cloning of disease-resistant genes.
Through genome-wide association analysis (GWAS) accurately identified the site of the MEB2 gene as a key site for the regulation of sclerosis resistance in the natural population of rapeseed, and constructed the Arabidopsis meb2 mutant and overexpression strain. Combined with the verification of the transgenic function of rapeseed, it was confirmed that the loss of the MEB2 gene function can significantly improve the plant disease resistance, while overexpression leads to increased sensory disease.
The regulation of plant resistance to sclerosis through functional deletion or overexpression of the MEB2 gene is achieved, providing new theoretical basis and methods to achieve disease-resistant molecular breeding, and a haplotype classification method based on 16 SNP sites in the BnMEB2 gene region was developed for molecular marker-assisted selection of disease-resistant phenotypes.
Smart Images

Figure CN120230789A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of molecular biotechnology, in particular to application of MEB2 gene in negatively regulating plant sclerotinia resistance. Background Art
[0002] Plant fungal diseases, a major threat to agricultural production, have long severely restricted crop yield and quality. Among them, diseases caused by necrotrophic fungal pathogens, due to their unique pathogenic mechanisms and wide host range, have become a key challenge in agricultural production. Sclerotinia sclerotiorum, a typical example of this pathogen, can infect a variety of important economic crops, including those in the crucifer and legume families, causing sclerotinia disease and resulting in significant economic losses.
[0003] Take rapeseed as an example. As the world's second largest oil crop, its yield and quality are directly related to the country's edible oil safety and the stable development of the agricultural economy. However, the frequent outbreaks of sclerotinia rot in rapeseed production have become a major bottleneck restricting the sustainable development of the rapeseed industry. This disease not only directly causes a loss of up to 10%-20% in rapeseed yield, but also significantly reduces the quality of rapeseed oil, including a decrease in oil content and changes in fatty acid composition, seriously threatening the long-term healthy development of the rapeseed industry. Faced with the severe challenge of sclerotinia rot, traditional prevention and control methods such as chemical control can alleviate the disease pressure to a certain extent, but long-term use can easily lead to environmental pollution, increased pathogen resistance, and excessive pesticide residues in agricultural products, which does not meet the requirements of sustainable development of modern agriculture. Therefore, breeding disease-resistant varieties as a green, economical and safe way to prevent and control diseases has become a consensus and key research direction in the current agricultural scientific research field.
[0004] However, the breeding process for Sclerotinia sclerotinia resistance faces many challenges. On the one hand, since plant materials that are completely immune to Sclerotinia sclerotinia have not yet been discovered, traditional breeding methods are difficult to quickly obtain ideal disease-resistant varieties. On the other hand, existing research shows that plant resistance to Sclerotinia sclerotinia is controlled by multiple genes and exhibits quantitative genetic characteristics, that is, disease resistance is determined by the combined action of multiple major and minor genes. This genetic complexity increases the difficulty of locating and cloning disease-resistant genes, limiting the in-depth development of disease-resistant breeding. Therefore, discovering new disease-resistant gene resources and exploring their application potential in disease-resistant breeding are of great significance for breaking through the current technical bottlenecks of Sclerotinia sclerotinia resistance breeding and promoting the genetic improvement of disease resistance in crops such as rapeseed. Summary of the Invention
[0005] In view of this, the present invention proposes the use of the MEB2 (Membrane Protein of Endoplasmic Reticulum Body 2) gene in negatively regulating plant resistance to sclerotinia sclerotiorum.
[0006] The technical solution of the present invention is achieved as follows:
[0007] In a first aspect, the present invention provides an application of the MEB2 gene in negatively regulating plant resistance to sclerotinia sclerotiorum, wherein the MEB2 gene is the BnaC07G30170D gene or the AT5G24290 gene; and the plant is rapeseed or Arabidopsis thaliana;
[0008] The negative regulation is as follows (1) or (2):
[0009] (1) The MEB2 gene is functionally lost, and the plant's resistance to sclerotinia sclerotiorum is enhanced;
[0010] (2) The MEB2 gene is overexpressed, and the plant is susceptible to sclerotinia disease.
[0011] The nucleotide sequence of the MEB2 gene is one of SEQ ID NOs: 1-3.
[0012] In some specific embodiments, the MEB2 gene functional loss includes reducing or eliminating the expression of the MEB2 gene by using gene mutation, gene knockout, gene interference or gene silencing technology.
[0013] In a second aspect, the present invention provides the use of the transcript AtMEB2.1 or AtMEB2.2 in regulating resistance to sclerotinia sclerotinia in Arabidopsis thaliana. The locus of the transcript AtMEB2.1 in the TAIR database is AT5G24290.1; the cDNA sequence of the transcript AtMEB2.2 is shown in SEQ ID NO: 4. In some specific embodiments, overexpression of the transcript AtMEB2.1 or AtMEB2.2 increases plant susceptibility to sclerotinia sclerotinia.
[0014] In a third aspect, the present invention provides an application of the rapeseed BnMEB2 gene in the identification of rapeseed resistance to sclerotinia sclerotiorum, with reference to the rapeseed genome Darmor-bzh v4.1, at the physical positions 34748484, 34748494, 34748655, 34748690, 34748835, 34749302, 34749303, 34749330, 34749439, 34749451, 34749513, 34749655, 34750334, 34750736, 34751328 and 34751950 of the BnMEB2 gene on chromosome C07, a total of 16 SNP sites; the haplotype at the SNP site is SEQ ID The resistance of rapeseed with SNP NO: 29 (GATATTGGCAAAAAGG) to sclerotinia rot was superior to that of rapeseed with the haplotype of SEQ ID NO: 30 (AGCTCCCATGTGGTCA) at the SNP site. The haplotype typing results of the SNP site and its corresponding rapeseed germplasm resources are shown in the following table:
[0015]
[0016] In a fourth aspect, the present invention provides a method for identifying rapeseed's resistance to sclerotinia disease. Referring to the rapeseed genome Darmor-bzh v4.1, the genotypes of 16 SNP sites of rapeseed at the physical positions 34748484, 34748494, 34748655, 34748690, 34748835, 34749302, 34749303, 34749330, 34749439, 34749451, 34749513, 34749655, 34750334, 34750736, 34751328 and 34751950 at chromosome C07 of the BnMEB2 gene are detected. The sclerotinia disease resistance of rapeseed whose haplotype at the SNP site is SEQ ID NO: 29 is better than that of rapeseed whose haplotype at the SNP site is SEQ ID NO: 30.
[0017] In some specific embodiments, the detection method includes sequencing, PCR amplification, specific probe hybridization method, specific primer extension method or gene chip method.
[0018] In a fifth aspect, the present invention provides application of the identification method in breeding rapeseed resistant to sclerotinia sclerotiorum.
[0019] The beneficial effects of the present invention include at least the following:
[0020] This study, using genome-wide association studies (GWAS), accurately identified the MEB2 gene locus as a key site for regulating Sclerotinia sclerotiorum resistance in natural rapeseed populations. By constructing Arabidopsis meb2 mutants and overexpression lines, combined with transgenic rapeseed functional validation, the study confirmed that loss of MEB2 gene function significantly enhances plant disease resistance, while overexpression increases susceptibility.
[0021] The present invention discloses for the first time the transcript AtMEB2.2, whose overexpression significantly enhances the susceptibility of plants to Sclerotinia sclerotiorum, indicating that AtMEB2.2 is involved in the negative regulatory pathway of disease resistance, providing a new theoretical basis for achieving molecular breeding of disease resistance by targeted regulation of specific splicing isoforms.
[0022] In response to the needs of rapeseed breeding, the present invention has developed a haplotype typing method based on 16 SNP sites in the BnMEB2 gene region, realizing molecular marker-assisted selection of disease-resistant phenotypes, and has important application prospects in the fields of rapid field disease-resistant phenotype screening and germplasm creation of crops such as rapeseed. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the following briefly introduces the drawings required for use in the description of the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.
[0024] Figure 1 GWAS analysis (Genome-Wide Association Study) and haplotype map (HapMap) of sclerotinia resistance in rapeseed population: Figure 1 A is the Manhattan plot of GWAS analysis of rapeseed population; Figure 1 B is the quality control chart of GWAS analysis of rapeseed population; Figure 1 C is the linkage disequilibrium analysis diagram of the BnMEB2 gene locus; Figure 1 D is the haplotype diagram of single base variation in the BnMEB2 gene region in the population;
[0025] Figure 2 This is a sequence comparison analysis diagram of rapeseed MEB2 and closely related species: Figure 2 A is the evolutionary tree constructed based on the homologous sequences of BnMEB2 in rapeseed, its ancestral species Brassica rapa and Brassica oleracea, and the model plant Arabidopsis thaliana; Figure 2 B is a diagram showing the colinearity of the homologous sequences of BnMEB2 in rapeseed and its ancestral species, Chinese cabbage and Brassica oleracea;
[0026] Figure 3The sequence, expression and molecular identification diagram of the two alternative splice forms of AtMEB2, AtMEB2.1 and AtMEB2.2, as well as the genetic material created: Figure 3 A is a diagram of the gene structure analysis of AtMEB2.1 and AtMEB2.2; Figure 3 B is the expression diagram of AtMEB2.1 and AtMEB2.2 in roots, stems, leaves, flowers (flowers include small buds, middle buds, and fully opened flowers) and siliques; Figure 3 C is the expression diagram of AtMEB2.1 and AtMEB2.2 in transgenic lines overexpressing in wild type and meb2 mutant, respectively; wherein lanes: 1 is 35S:MEB2.1 / WT (line overexpressing AtMEB2.1 in wild type); 2 is 35S:MEB2.2 / WT (line overexpressing AtMEB2.2 in wild type); 3 is WT (wild type); 4 is meb2 mutant; 5-7 are 35S:MEB2.1 / meb2 (line overexpressing AtMEB2.1 in meb2 mutant); 8-10 are 35S:MEB2.2 / meb2 (line overexpressing AtMEB2.2 in meb2 mutant);
[0027] Figure 4 Phenotypic identification diagram of AtMEB2.1 and AtMEB2.2 overexpression, meb2 mutant and wild-type Arabidopsis inoculated with Sclerotinia sclerotiorum: Figure 4 A and 4C are phenotypes of sclerotinia lesions; Figure 4 B and 4D are statistical graphs of the sclerotinia lesion area; (Note: experimental time point, such as "60 hpi" means 60 hours after inoculation; the control group is the untransformed wild type: WT);
[0028] Figure 5 Phenotypic identification of T1 transgenic lines overexpressing BnMEB2 in rapeseed after inoculation with Sclerotinia sclerotiorum: Figure 5 A is the expression diagram of BnMEB2 in the BnMEB2 overexpression line; Figure 5 B is the statistical graph of the area of sclerotinia lesions; Figure 5 C is the phenotype of sclerotinia lesions; (Note: experimental time point, such as "24 hpi" means 24 hours after inoculation; the control group is untransformed wild type ZS11 and empty vector EV). DETAILED DESCRIPTION
[0029] In order to make the purpose, technical solutions and advantages of the present invention clearer, the technical solutions of the present invention will be clearly and completely described below. Obviously, the embodiments described are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention. If the specific conditions are not specified in the examples, the experiments shall be carried out according to conventional conditions or the conditions recommended by the manufacturer. The reagents or instruments used without indicating the manufacturer are all conventional products that can be purchased commercially. The experimental methods for which the specific conditions are not specified in the examples shall be carried out in accordance with the "Molecular Cloning Experiment Guide" (4th edition) or the instructions of the relevant kits.
[0030] Table 1 Sequence information
[0031]
[0032] Example 1
[0033] 1. Genome-wide association study (GWAS) of Sclerotinia sclerotiorum resistance in rapeseed
[0034] This application uses 128 natural rapeseed germplasm resources (Table 2). When rapeseed plants reach the 4-5 leaf stage, the second and third leaves are cut off and inoculated with Sclerotinia sclerotiorum in vitro in a greenhouse (22-24°C, 16 h light / 8 h dark). Sclerotinia sclerotia were first germinated on potato culture medium (potato dextrose agar purchased from BD Biosciences, USA, catalog number 6117503, preparation method see instructions). Activated mycelial blocks (5 mm × 5 mm diameter) were inoculated onto leaves. 24 h after inoculation, the lesion area was measured to obtain phenotypic data on Sclerotinia resistance in the population (for specific methods, refer to the paper: Zhang et al., Syntenic QTL and genomic divergence for Sclerotinia resistance and flowering time in Brassica napus. Journal of Integrative Plant Biology. 2019, 61(1): 75-88).
[0035] Population resequencing was commissioned by BGI-Shenzhen. Using the Illumina HiSeqXTen platform, 7.36 Gb of short, adapter-free sequences were generated, aligned to the rapeseed reference genome (Darmor-bzh v4.1, http: / / www.genoscope.cns.fr / plants). Sequencing depths ranged from 6.02× to 17.03×. SNPs were identified for each accession using the Sentieon DNAseq pipeline. Initially identified SNPs were filtered using the GATK function variantFiltration (with filtering parameters of QUAL < 30 || MQ < 50 || QD < 2). Low-frequency bases and mismatch rates were then filtered (MAF > 0.05 || missing rate < 0.1). A total of 2,288,712 high-quality SNPs were identified for GWAS analysis. GWAS analysis was performed using mixed linear models in EMMAX software.
[0036] The analysis results showed that there was a significant association locus on chrC07 (chromosome C07), and linkage disequilibrium analysis showed that this region was a highly linked module ( Figure 1 AC), as shown in Table 3, a candidate gene BnMEB2 (BnaC07g30170D) was screened at this site, and its haplotype typing (Table 4) showed that the two haplotypes divided by the single base variation in this gene region had extremely significant differences in sclerotinia resistance, and the sclerotinia resistance of haplotype II was significantly better than that of haplotype I at the SNP site. ( Figure 1 D).
[0037] Table 2. Information of 128 rapeseed germplasm resources
[0038]
[0039] Table 3. GWAS identified a locus significantly associated with resistance to Sclerotinia sclerotiorum in rapeseed.
[0040]
[0041] Table 4. Haplotypes of the BnMEB2 gene in rapeseed populations
[0042]
[0043] GWAS analysis based on 128 rapeseed germplasms (P=1.35×10⁻¹ 5, Manhattan plot threshold -Log10(P)=5), pinpointing the BnMEB2 gene (BnaC07g30170D) as the major locus for sclerotinia resistance. Haplotype analysis revealed that accessions carrying haplotype II (SEQ ID NO: 29) had a mean lesion area of 1.08 cm² 24 hours after inoculation, significantly higher than accessions carrying haplotype I (SEQ ID NO: 30) (t-test, P<0.01). The LD value (r²) in this region was greater than 0.73, indicating that the 16 SNPs (ChrC07: 34,748,484-34,751,950) are closely linked markers.
[0044] 2. Comparative analysis of BnMEB2 and its homologous gene sequences in Arabidopsis
[0045] The BnMEB2 gene sequence was obtained through genomic data resources, and the relationship was analyzed through homology search, sequence alignment and phylogenetic tree construction. The results showed that BnMEB2 is highly homologous to the Arabidopsis AtMEB2 gene ( Figure 2 A), Collinearity analysis confirmed that BnMEB2 has orthologous genes in Brassica rapa (Bra037799) and Brassica oleracea (Bo5g024370), and the genomic region where MEB2 is located is highly conserved ( Figure 2 B). This indicates that the gene structures of BnMEB2 and AtMEB2 are highly conserved and their functions may be similar.
[0046] Example 2 Cloning and expression pattern analysis of two alternative splice variants of Arabidopsis MEB2, AtMEB2.1 and AtMEB2.2
[0047] For ease of description, the two AtMEB2 transcripts are designated AtMEB2.1 (Locus: AT5G24290.1; https: / / www.arabidopsis.org / locus?key=134054#) and AtMEB2.2. AtMEB2.1 is the reported major transcript. AtMEB2.2 (nucleotide sequence shown in SEQ ID NO: 4) is the alternatively spliced variant disclosed for the first time in this application. Compared with AtMEB2.1, it has two key differences: the 5' untranslated region (5' UTR) of AtMEB2.2 is 86 base pairs shorter, and the second exon of AtMEB2.2 is 48 base pairs shorter than that of AtMEB2.1.
[0048] The method of this embodiment is as follows:
[0049] (1) Primer design and template preparation: Based on the AtMEB2 gene sequence information on the Arabidopsis TAIR website (http: / / www.arabidopsis.org / ), three pairs of primers were designed as shown in SEQ ID NOs: 5-10. Young leaves of Arabidopsis thaliana ecotype Columbia were quickly frozen in liquid nitrogen and total RNA was extracted using the Trizol method (Invitrogen, Catalog No. 15596026). Reverse transcription was performed using Superscript™ Reverse Transcriptase (Promega, Catalog No. M1701) to obtain cDNA; this was used as the template.
[0050] (2) PCR amplification: PCR amplification was performed using Ex Taq DNA high-fidelity polymerase. The amplification system in 50 μl included 4 μl of dNTPs (10 mmol / L), 5 μl of 10× Taq buffer, 1 μl of 5' primer (10 μmmol / L), 1 μl of 3' primer (10 μmmol / L), 0.5 μl of Taq (5 U / μl), 1 μl of cDNA template, and 37.5 μl of ddH2O. The PCR amplification reaction conditions were as follows: pre-denaturation at 94°C for 5 min; 30 cycles of denaturation at 94°C for 45 s, annealing at 58°C for 45 s, and extension at 72°C for 2.5 min; and extension at 72°C for 10 min. PCR products were identified by electrophoresis on a 1% (mass / volume) agarose gel. PCR products were purified using the Tiangen Agarose Gel DNA Recovery Kit (DP209, TIANGEN). The experimental procedures and instructions were referred to the kit instructions. The concentration of PCR products recovered from gel was determined using Nanodrop 2000, and then the product was purified using Takara's PMD19-T Vector kit (D102A, Takara).
[0051] (3) Clone construction and variable splicing identification: The PCR product was connected to the PMD19-T vector. For specific experimental steps and methods, please refer to the kit instructions. In a 10 μl reaction system, 4 μl of purified PCR product, 1 μl of PMD19-T Vector, and 5 μl of ligase were recovered; after gently blowing with a pipette to mix, the ligation was carried out at 16°C overnight. The ligation product was transformed into Escherichia coli DH5α cells using a heat shock method (freeze-thaw competent cells, add 10 μL of the recombinant plasmid, mix well, and incubate on ice for 5 minutes; freeze in liquid nitrogen for 5 minutes; and incubate in a 37°C waterbath for 5 minutes). The cells were then revived for 1 hour by adding 800 μL of liquid LB medium (2.5 g yeast extract, 5 g peptone, 5 g sodium chloride, and 0.5 L sterile water, autoclaved at 120°C for 20 minutes). The cells were then plated onto solid LB plates containing ampicillin-resistant strains (2.5 g yeast extract, 5 g peptone, 5 g sodium chloride, 7 g agar powder, and 0.5 L sterile water, autoclaved at 120°C for 20 minutes) and incubated at 37°C for 14 hours. The next day, single colonies were randomly picked with a sterile toothpick and positive colonies were amplified by colony PCR using the M13 universal primer (PCR amplification conditions, procedures, and detection are the same as above).
[0052] Positive clones were inoculated into LB liquid medium containing ampicillin and cultured overnight at 37°C. Plasmids were then extracted using Tiangen's Plasmid Extraction Kit, DP103, and sent to Qingke for sequencing. Sequencing analysis revealed that AtMEB2 undergoes alternative splicing in the 5' UTR and second exon, generating two alternative splice variants, AtMEB2.1 and AtMEB2.2. The 5' UTR (5' untranslated region) of AtMEB2.2 is 86 bp shorter than that of AtMEB2.1, and the second exon of AtMEB2.2 is 48 bp shorter than that of AtMEB2.1. Figure 3 A).
[0053] (4) Tissue expression pattern detection: To further detect the expression patterns of the two alternative splicing variants, samples from different tissues of Arabidopsis thaliana (including leaves, stems, small flower buds, medium flower buds, fully opened flowers, roots, and siliques) were collected, RNA was extracted and reverse transcribed into cDNA, and the cDNA was diluted to a uniform concentration (20 ng / L) and used as a template for semi-quantitative PCR amplification. The AtMEB2 primers in the semi-quantitative PCR are shown in SEQ ID NOs: 11 and 12, and the internal reference gene is the Arabidopsis β-actin encoding gene (Actin) (Locus: AT1G13810; https: / / www.arabidopsis.org, and the primers are shown in SEQ ID NOs: 13 and 14). The PCR amplification conditions, procedures, and detection methods are the same as above.
[0054] resultThe results showed that the two alternative splicing variants were expressed in multiple tissues (including leaves, stems, small flower buds, medium flower buds, fully opened flowers, roots and siliques), but the expression level of AtMEB2.1 was higher than that of AtMEB2.2 ( Figure 3 B).
[0055] Example 3 Overexpression of AtMEB2.1 and AtMEB2.2 and Construction of Complementary Genetic Materials
[0056] To explore the sclerotinia resistance function of AtMEB2, we constructed AtMEB2.1 and AtMEB2.2 overexpression vectors and genetically transformed them into wild-type Arabidopsis thaliana and meb2 mutant (GABI_059D03, T-DNA inserted into the second exon of AtMEB2, Figure 3 A) The steps are as follows:
[0057] (1) Construction of overexpression vector and transformation and verification of recombinant plasmids: Using primers (as shown in SEQ ID NO: 15-18), the complete coding region sequences of AtMEB2.1 and AtMEB2.2 (as shown in SEQ ID NO: 2-3) were amplified by PCR from the recombinant plasmids PMD-19-AtMEB2.1 and PMD-19-AtMEB2.2 templates. The PCR reaction system (50 μl) consisted of: 2 μl cDNA, 2 μl forward / reverse primers (10 μM) each, 25 μl 2×Phanta Max Master Mix, and 19 μl ddH2O. The samples were added on ice and mixed thoroughly. The PCR reaction conditions were: 95 o C 3 min; 95 o C 15 sec, 53 o C 15 sec, 72 o C 90 sec, 32 cycles; 72 oC for 10 min. The target fragment and expression vector PBI121 plasmid (Shenzhen Kangti Life Science Technology Co., Ltd.) were recovered by agarose gel electrophoresis and digested separately using the following enzyme digestion system: 30 μl of target fragment / expression vector, 5 μl of 10× buffer, 2 μl each of Bam HI and Xba I (10 U / μl), and 11 μl of ddH2O. The plates were incubated in a 37°C water bath for 3-5 h, and the digestion results were verified by agarose gel electrophoresis. The digestion products were purified using the Tiangen Agarose Gel DNA Extraction Kit (DP209), following the manufacturer's instructions. The digestion products were ligated using the following system: 5 μl of target fragment, 1 μl of target vector fragment, 1 μl of 10× buffer, 1 μl of T4 DNA ligase (350 U / μl), and 1 μl of ddH2O. Mix thoroughly by gently pipetting, seal the plate, and incubate the ligation overnight at 16°C. The ligation product was transformed into Escherichia coli cells (resistant to kanamycin) using the same protocol as above. Positive clones were identified by PCR in the culture medium, and plasmids were extracted from the culture medium and sent to Qingke for sequencing. The recombinant plasmids, which contained no base errors in the sequencing, were then heat-shocked into Agrobacterium tumefaciens EHA105 competent cells. After freeze-thawing, 10 μL of the recombinant plasmid was added, mixed, and incubated on ice for 5 minutes. The cells were then frozen in liquid nitrogen for 5 minutes and then incubated in a 37°C waterbath for 5 minutes. Fresh antibiotic-free liquid LB medium was then added, mixed, and activated at 28°C at 220 rpm for 2 hours. Finally, the cells were plated onto solid LB plates containing kanamycin and rifampicin and incubated in the dark at 28°C for 2 days. Positive single clones were identified using the primers described above.
[0058] (2) Arabidopsis transformation and transgenic result verification: Positive clones were selected and expanded in LB liquid medium containing kanamycin and rifampicin for Arabidopsis transformation. Wild-type Arabidopsis (Columbia ecotype) and meb2 mutant were transformed using Agrobacterium-mediated floral dip method to construct AtMEB2.1 and AtMEB2.2 overexpression materials in wild type and complementation materials in meb2 mutant, respectively. RNA was extracted from leaves of transgenic Arabidopsis thaliana overexpressing and complementing AtMEB2.1 and AtMEB2.2, as well as leaves of wild type and meb2 mutant, and reverse transcribed into cDNA. The RNA was diluted to the same concentration (20 ng / μl) and used as template for semi-quantitative PCR to detect the expression of the target gene. The AtMEB2.1 and AtMEB2.2 specific primers used are shown in SEQ ID NO: 19-22.
[0059] Results: As Figure 3As shown in C, compared with the brightness of the AtMEB2.1 and AtMEB2.2 bands in the wild type in the third lane, the brightness of the target gene bands in the AtMEB2.1 and AtMEB2.2 overexpression lines in the first and second lanes was significantly enhanced, that is, overexpression; compared with the almost undetectable expression bands of AtMEB2.1 and AtMEB2.2 in the meb2 mutant in the fourth lane, the bands of the transgenic line AtMEB2.1 in which AtMEB2.1 was complemented to meb2 in lanes 5 to 7 were clearly visible, and the bands of the transgenic line AtMEB2.2 in which AtMEB2.2 was complemented to meb2 in lanes 8 to 10 were also bright, that is, the complementation was successful.
[0060] Example 4 Identification of Sclerotinia resistance in AtMEB2 transgenic plants
[0061] The transgenic positive plants obtained above were cultured in a greenhouse until they were 4 weeks old and then subjected to an in vitro inoculation experiment with Sclerotinia sclerotiorum. The steps were as follows:
[0062] 1) Activation of Sclerotinia: First, sterilize the sclerotia of Sclerotinia stored in the laboratory (treat with 75% alcohol for 1 minute, then with 0.1% mercuric chloride for 5 minutes, and then wash with sterile water 3-5 times). Then, cut the sclerotia with a sterile knife and inoculate the cross section of the sclerotia into the center of PDA solid medium (PDA solid medium is dissolved according to the instructions of potato dextrose agar, autoclaved at 121°C for 15 minutes). After sealing with parafilm, incubate in a 24°C incubator for 72 hours. In a sterile clean bench, use a sterile punch to punch 5 mm × 5 mm mycelial blocks along the edge of the mycelium and inoculate into Minimal Place the solid culture medium (2 g ammonium sulfate, 1 g sodium hydroxide, 3 g DL-malic acid, 0.1 g magnesium sulfate heptahydrate, 39 g bacterial agar powder, add sterile water to 1 L, adjust the pH to 5.8-6.0, and autoclave at 115°C for 15 min) in the center and culture in a 24°C incubator for 48 h.
[0063] 2) Inoculation of Arabidopsis leaves with Sclerotinia sclerotiorum: When hyphae have grown to 2 / 3 of the medium, use a sterile borer to punch 2 mm x 2 mm mycelial plugs along the edge of the mycelium for inoculation. AtMEB2.1 and AtMEB2.2 overexpressing and complementing transgenic lines, as well as Arabidopsis and meb2 mutants, were seeded and cultured in a growth chamber for 4 weeks. When plants reached their full leaf size and had not yet bolted, live inoculation was performed. The prepared mycelial plugs were removed with a paperclip and inoculated onto Arabidopsis leaves (3-5 plugs per plant). After inoculation, water was sprayed to maintain moisture (humidity >80%) and the culture was closed.
[0064] 3) Spot area statistics: Measure the length and width of the leaf spots with a ruler 24h, 36h, 48h, and 60h after inoculation.
[0065] Results: As Figure 4 As shown, the lesion area of the Arabidopsis meb2 mutant after inoculation with Sclerotinia sclerotiorum was significantly reduced compared to the wild type (P<0.001). The lesion area of strains overexpressing AtMEB2.1 and AtMEB2.2 (with significantly increased expression levels verified by RT-PCR) was significantly increased compared to the wild type. Complementation experiments showed that overexpressing AtMEB2.1 / AtMEB2.2 in the meb2 mutant restored the lesion area to a level not significantly different from that of the wild type (P>0.05), demonstrating that these two alternative splice variants of AtMEB2 can, to some extent, compensate for the reduced resistance caused by the mutation in the meb2 mutant.
[0066] Example 5
[0067] 1. Susceptible haplotype gene cloning and vector construction
[0068] To clone the susceptible haplotype of BnMEB2, RNA was extracted from leaves of rapeseed Westar and reverse transcribed into cDNA as a template. Based on the sequence information of the C07 copy of BnMEB2 (BnaC07T0360300WE) in the published Westar genome (https: / / bnaomics.ocri-genomics.net / ), primers (as shown in SEQ ID NOs: 23 and 24) were designed to amplify the complete reading frame of BnMEB2ws_C07 (BnaC07g30170D) (as shown in SEQ ID NO: 1) by PCR. The amplified products were detected by agarose gel electrophoresis, purified and recovered using the same method as above, and the concentration of the recovered fragments was determined. Then, the recovered fragments were ligated with the laboratory-modified plant expression vector PGTV II-3FLAG linear vector by homologous recombination (homologous recombination kit was purchased from Novozymes, and the recombination system and method were referred to the kit instructions). The ligation system (20 μl) included: 12 μl of PGTVII-3FLAG linear vector, 1 μl of BnMEB2ws_C07 purified product, 2 μl of Exnase II, and 5 μl of 5×CE buffer. 10 μl of the ligation product was transformed into competent E. coli cells using the same method as described above. The cells were revived in 800 μl of liquid LB medium for 1 hour, spread onto solid LB plates containing kanamycin resistance, and incubated at 37°C for 14 hours. Colony PCR was performed to verify the size of the target gene fragment in the recombinant vector (primers used are shown in SEQ ID NOs: 23 and 24). Positive colonies were expanded, and the recombinant plasmid was extracted and sent to Qingke Biotechnology for sequencing. Sequencing analysis showed that the recombinant plasmid contained an intact open reading frame, indicating that the BnMEB2ws_C07 overexpression vector was successfully constructed. The recombinant plasmid was extracted and transformed into Agrobacterium cells using the same method as described above. Positive clones were identified by single-clone PCR, and plasmids were extracted and sequenced. Agrobacterium strains containing positive plasmids were used for subsequent rapeseed genetic transformation.
[0069] 2. Genetic transformation and strain screening of rapeseed
[0070] The BnMEB2ws_C0 overexpression vector was introduced into the rapeseed variety Zhongshuang 11 (ZS11) using Agrobacterium-mediated hypocotyl transformation. Four T1 generation overexpression lines (#2, #7, #11, and #13) were obtained after hygromycin resistance screening (using universal primers) and PCR verification using gene-specific primers (primers: SEQ ID NOs: 23 and 24). Total RNA was extracted from young tissues of the transgenic plants and ZS11 using the same method as described above. The RNA was reverse-transcribed into cDNA, which served as a template (the template concentration was adjusted to a Ct value of 18-22 for the rapeseed internal reference gene Actin (AF111812, primers shown in SEQ ID NOs: 25 and 26) using quantitative RT-PCR (qRT-PCR). Primers SEQ ID NOs: 27 and 28 were used to detect the expression of BnMEB2ws_C07 in each accession. PCR reaction system (20 μL): 1 μL cDNA, 1 μL each of forward and reverse primers (10 μM), 10 μL 2× SYBR Green Master Mix (Yisheng Biotechnology, Cat. No. 11184ES), and 7 μL ddH2O. Add the sample and mix well on ice. PCR reaction conditions were: 95°C for 5 min; 95°C for 15 sec, 58°C for 30 sec, 72°C for 15 sec, 40 cycles; 95°C for 15 sec, 60 sec, and 95°C for 15 sec. 2 -ΔΔCT The relative expression level of the target gene was calculated by this method.
[0071] The results showed that the expression level of BnMEB2 in the transgenic lines was significantly higher than that in ZS11 and empty vector (EV) ( Figure 5 A).
[0072] 3. In vitro leaf inoculation experiment of Sclerotinia sclerotiorum
[0073] The four strains overexpressing BnMEB2ws_C07, an empty vector (PGTV II-3FLAG vector without the target fragment), and ZS11 were cultured in the growth chamber until the 4-5 leaf stage and then inoculated with Sclerotinia sclerotiorum detached leaves:
[0074] 1) Activation of Sclerotinia sclerotiorum is performed in the same manner as described above for inoculation with Arabidopsis thaliana. Sterilized, cut sclerotia are placed on a PDA solid culture medium. When hyphae grow to 2 / 3 of the medium, use a sterile borer to punch holes (5 mm x 5 mm in diameter) at the edge of the hyphae. The resulting mycelial mass is then used for inoculation of rapeseed leaves.
[0075] 2) Take the second and third leaves of each plant of each material at the 4-5 leaf stage and lay them flat on a box with two layers of absorbent paper (add water to make it wet). Cut 15-20 leaves from each material.
[0076] 3) Use a paper clip to inoculate the prepared mycelium block with the mycelium facing downwards onto both sides of the main vein of the rapeseed leaf (avoiding the veins). After inoculation, spray water to keep it moist (80% humidity) and then seal the lid for culture.
[0077] 4) Plaque measurements were performed 24 hours after inoculation using the same method as described above. The results showed that compared to the controls (ZS11 and empty vector), the lesions in the BnMEB2 overexpressing strains were significantly larger. Phenotypic observations revealed that large water-soaked lesions appeared on the transgenic leaves, and the mycelial spread was accelerated ( Figure 5 B and 5C).
[0078] in conclusion Overexpression of BnMEB2 in rapeseed significantly enhances susceptibility to Sclerotinia sclerotiorum and promotes its development, consistent with its negative regulatory role in resistance in Arabidopsis. This result corroborates the GWAS-linked haplotype effect, and the BnMEB2 gene dosage effect is moderately correlated with susceptibility (R²=0.02).
[0079] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.
Claims
1. Transcript AtMEB2.2 Application in regulating Sclerotinia sclerotiorum resistance of Arabidopsis thaliana, characterized in that The transcript AtMEB2.2 has a cDNA sequence as shown in SEQ ID NO:
4.
2. The application according to claim 1, characterized in that, Overexpression through the said transcript AtMEB2.2 promotes the susceptibility of plants to Sclerotinia sclerotiorum.
3. Rapeseed BnMEB2 Application of the gene in rapeseed Sclerotinia sclerotiorum resistance identification, characterized in that Reference rapeseed genome Darmor- bzh v4.1, at positions 34748484, 34748494, 34748655, 34748690, 34748835, 34749302, 34749303, 34749330, 34749439, 34749451, 34749513, 34749655, 34750334, 34750736, 34751328, and 34751950 on the physical position of chromosome C07 of the BnaC07g30170D gene, a total of 16 SNP loci; the resistance to Sclerotinia sclerotiorum of rapeseed with the haplotype of SEQ ID NO: 29 at the SNP loci is superior to that of rapeseed with the haplotype of SEQ ID NO: 30 at the SNP loci.
4. A method for identifying the resistance to Sclerotinia sclerotiorum in rapeseed, characterized in that, Reference rapeseed genome Darmor- bzh v4.1, detection of rapeseed in BnMEB2 The genotypes of 16 SNP sites at the physical location 34748484, 34748494, 34748655, 34748690, 34748835, 34749302, 34749303, 34749330, 34749439, 34749451, 34749513, 34749655, 34750334, 34750736, 34751328 and 34751950 of the chromosome of gene C07, and the rapeseed whose haplotype at the SNP site is SEQ ID NO: 29, have better resistance to sclerotinia than the rapeseed whose haplotype at the SNP site is SEQ ID NO:
30.
5. The identification method according to claim 4, characterized in that, The detection method includes sequencing, PCR amplification, specific probe hybridization method, specific primer extension method or gene chip method.
6. Use of the identification method according to claim 4 or 5 in breeding of rapeseed resistant to Sclerotinia sclerotiorum.
Citation Information
Patent Citations
SNP markers closely linked with height trait of cabbage type rape, and application of SNP markers
CN110578015A
Extension factor BnELP2 gene for regulating and controlling sclerotinia rot resistance of brassica napus and application of extension factor BnELP2 gene
CN117778456A
Brassica napus BnaWRKY40 gene and application thereof in sclerotiniose resistance
CN117965561A
Application of brassica napus drought negative regulation gene BnaC07.MYB77
CN118995741A
Arabidopsis thaliana atbzip28 gene responding endoplasmic reticulum stress and use thereof
KR1020080055483A
